Women who have had breast cancer and risk recurrence or who are at high risk for breast cancer may see those odds increase while using some types of hrt. While some forms of hormone replacement therapy have been found to increase breast cancer risk, therapies that use only estrogen may actually protect women against the disease, a new study says. Hrt is also called estrogen estrojin replacement therapy or ert. For some, the benefits of taking hrt may outweigh the risks, so talk to. Hormone therapy for menopause raises breast cancer risk for. Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of followup. Whether hormone patches affect breast cancer recurrence or breast cancer risk is under study. Some medical treatments can change hormone levels, including hrt. Hormone replacement therapy hrt and breast cancer risk breast. Learn how hormone therapy ht during menopause can affect a. Breast tenderness with estrogen replacement therapy. Most of our understanding about the benefits and risks of hormone therapy on the heart and breast come from the womens health initiative whi study one. Hormone replacement therapy hrt is a treatment for women who have low hormone levels, like a woman going through menopause.
If you are bothered by menopause symptoms, talk to your doctor about other ways to get help. A large study found that women who took estrogen hrt after menopause were about twice as likely to develop benign not cancerous breast disease as women. There is a slight increased risk of breast cancer in women 5070 years old who have used hormone replacement therapy hrtfor greater than five years. In the womens health initiative, 8,506 women took combination hormone replacement therapy estrogen and progestin and were followed for an average of 5.
Talk with your provider about whether these products may be safe options for you. Risk is also higher in those who use hrt for more than 5 years. Your estrogen replacement therapy is typically made up of estradiol e2. Hormone therapy and other treatments for symptoms of. For example, in women who have had breast cancer, estrogen replacement may not be appropriate. You may also hear it described as hormone replacement therapy hrt, postmenopausal hormone therapy pht, or postmenopausal hormones pmh. Breast cancer was first shown to be associated with combined hrt treatment in 2003, when a large us trial found that the risk of developing breast cancer was 1. If your breast cancer was hormone receptorpositive, vaginal estrogen rings and suppositories are preferred over vaginal estrogen creams. It was big news in 2002 when researchers called a halt to a major governmentrun study of a hormone therapy used by millions of older women. Many women choose to skip hormone therapy for breast cancer in favor of natural alternatives. Hormone therapy for breast cancer fact sheet national. Further evidence about the effects of starting the use of such treatments well after.
Taking postmenopausal hormone therapy pht, also called hormone replacement therapy hrt, to help with menopause symptoms may not be safe for women who have had breast cancer. It does not discuss other possible risks of mht such as heart disease or stroke. Controlled studies and most observational studies published over the last 5 years suggest that the addition of synthetic progestins to estrogen in hormone replacement therapy hrt, particularly in continuouscombined regimen, increases the breast cancer bc risk compared to estrogen alone. These studies also showed that both combination and estrogenalone hormone use made mammography less effective for the early detection of breast cancer. A large ncisponsored randomized clinical trial called the breast cancer prevention trial found that tamoxifen, taken for 5 years, reduced the risk of developing invasive breast cancer by about 50%. Hormone therapy during menopause raises breast cancer risk. New study shakes up thinking on hormone replacement. Hormonal therapy is sometimes used to treat breast cancer. Researchers stopped the study, one of a series of clinical trials under the womens health initiative whi, after they found that longterm use of estrogen and progestin raised the risk of heart disease, stroke, blood clots, and invasive breast cancer. Hormone replacement therapy ups risk of benign breast disease. But it is biggest for those using combined hrt, which has the hormones oestrogen and progestogen. There was a myth going round if started before age 50. Similarly, routine mammograms and breast examinations are important to exclude the presence of breast cancer. Before the link between hrt use and breast cancer risk was established, many postmenopausal women took hrt for many years to ease menopausal symptoms hot flashes, fatigue and to reduce bone loss.
The risk of breast cancer increases for postmenopausal women using any type of hrt. Increased risk of dementia if hormone therapy is started after a woman has been in menopause for 10 years. Hormone therapy breast cancer lawsuits can proceed in. The women were evaluated for high risk by the gail model and were not found to be at increased risk of developing breast cancer. Most breast cancers are er positive, and clinical trials have tested whether hormone therapy can be used to prevent breast cancer in women who are at increased risk of developing the disease. If you arent bothered by menopausal symptoms and started menopause after age 45, you do not need hormone therapy to stay healthy. Why do women keep taking hrt despite breast cancer risks. The study also found a decreased risk of colorectal cancer, hip fractures, and total fractures with combined hormone therapy. In earlier clinical trials, combination hormone replacement therapy hrt consisting of progestin plus estrogen was linked to an increased risk of breast cancer and death from that disease. Postmenopausal serum sex steroids and risk of hormone receptorpositive and. Hormonal therapy for breast cancer canadian cancer society. The researchers found that combined hormone replacement therapy hrt with estrogen and progestin increases the risk of breast cancer, with.
For decades, women have used hormone therapy to ease symptoms of menopause, such as hot flashes and sweating. Hormone replacement therapy in carriers of the brca1. A sweeping new analysis adds to the evidence that many women who take hormone therapy during menopause are more likely to develop breast cancer. Menopausal hormone therapy and cancer national cancer. She also said the study showed menopausal hormone therapy at any age increased breast cancer risk. The european prospective investigation into cancer and nutrition. Others are terrified about the harm that this drug and others can do, and do not feel the purported benefits. The current practice is to use estrogenbased hormone therapy at least until the natural age of menopause, unless there is a medical reason a woman shouldnt receive it. While hormone therapy ht may be used in women with migraines or liver disease, certain types of hormone therapy ht often a patch or vaginal form may be. Typical estrogen replacement therapy uses this type of estrogen to help prevent hot flashes, night sweats, and other typical signs of menopause. In fact, for each year of estrogencontaining hormone replacement therapy, there was an 18% reduction in breast cancer risk when oophorectomy was performed before. This is the weakest of the three estrogens and is made in highest quantity during pregnancy. Jennifer litton, assistant professor of breast medical oncology, at the university of texas md anderson cancer center discusses hormone.
Consider risks before using hormone replacement therapy. Study suggests progestin, not estrogen, is the real cancer. Hormones are substances that control some body functions, including how cells act and grow. Hormone therapy during menopause raises breast cancer risk for years. This is called menopausal hormone therapy, and you may see it abbreviated as ht or mht. Type and timing of menopausal hormone therapy and breast. The risk of breast cancer was greater the longer women took the combined hormone therapy, but it decreased markedly when hormone use stopped. This is because many dont believe that tamoxifen, for example, is actually the wonder drug it is claimed to be. Study suggests hrt carries higher risk of breast cancer than. For many women, it appears that the benefits outweigh the risks. During followup, there was no significant difference noted in the proportion of women diagnosed with breast cancer between hormone replacement therapy users and nonusers 10. Type and timing of menopausal hormone therapy and breast cancer.
Collaborative group on hormonal factors in breast cancer. The results published in july 2002 showed the risks of combined hrt with estrogen plus progestin outweigh the benefits. Progestins and progesterone in hormone replacement therapy. Estrogenonly hormone replacement therapy may reduce. Published findings on breast cancer risk associated with different types of menopausal hormone therapy mht are inconsistent, with limited information on longterm effects. The risks of hrt can depend on whether estrogen is given alone or with progestin, the dosage and delivery. Changing the levels of hormones or blocking certain hormones can slow the growth and spread of breast cancer cells. Breast cancer there is a small increased risk of breast cancer in women who took combined estrogenprogestin therapy but not in women who took estrogen alone. The menopause patch and hrt can assist in managing the symptoms of menopause. It is a treatment that adds, blocks or removes hormones.
1413 343 1153 711 1298 1418 1400 608 76 170 657 1366 413 882 1160 385 1271 1126 550 877 35 711 1237 580 439 952 1245 1312 1680 96 1134 1102 700 117 305 1004 697 136 224 289 286 149 951 802 509 1069 116